Crowley Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-776
Closed -$35K 48
2025
Q3
$35K Hold
776
0.03% 166
2025
Q2
$35.9K Hold
776
0.03% 162
2025
Q1
$47.3K Buy
776
+21
+3% +$1.22K 0.05% 140
2024
Q4
$42.7K Buy
+755
New +$42.2K 0.04% 147

Other funds holding BMY

Crowley Wealth Management's BMY Position: Q4 2025 in Review

Crowley Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 776 shares — an estimated $35K sold.

Crowley Wealth Management first reported a position in BMY in Q4 2024 and held it in 4 quarters. The position peaked at $47.3K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Crowley Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 776 Bristol-Myers Squibb shares in Q4 2025, an estimated $35K.
  • Crowley Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 4 quarters.
  • Crowley Wealth Management's Bristol-Myers Squibb position peaked at $47.3K in Q1 2025.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.